GNH USA

Europe — EMA

Memantina Pharma Combix

GNH USA supplies Memantina Pharma Combix (Memantine), a NMDA receptor antagonist for moderate to severe Alzheimer's disease.

Memantine Hydrochloride

Request sourcing

1
Pack/s

What is Memantine Hydrochloride?

Memantine, the active ingredient in Memantina Pharma Combix, is a NMDA receptor antagonist presented as an unknown/unknown for oral use. It treats moderate to severe Alzheimer's disease in adults by modulating glutamatergic neurotransmission and reducing neuronal excitotoxicity.

GNH USA supplies Memantina Pharma Combix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Memantine Hydrochloride used for?

Memantine is indicated for the treatment of Alzheimer's disease, acting on the glutamatergic pathway to improve symptomatic outcomes.

- Moderate Alzheimer's disease: helps maintain cognition and daily activities. - Severe Alzheimer's disease: may improve functional abilities. - Overall Alzheimer's disease: supports symptomatic management of cognitive decline.

What are the side effects of Memantine Hydrochloride?

Memantine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate cranial pain. - Constipation: reduced bowel motility. - Confusion: transient mental clouding. - Fatigue: feeling unusually tired. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Seizures: convulsive episodes requiring immediate medical attention. - Hallucinations: visual or auditory disturbances. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Hepatic dysfunction: abnormal liver enzymes or jaundice. - Cardiac arrhythmias: irregular heart rhythm. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.

What precautions apply to Memantine Hydrochloride?

When prescribing Memantina Pharma Combix, consider the following safety measures.

- Renal impairment: monitor renal function and adjust therapy as needed. - History of seizures: use with caution and observe for increased seizure activity. - Cardiovascular disease: assess blood pressure and heart rate regularly. - Psychiatric conditions: watch for worsening agitation or psychosis. - Concomitant medications: review for potential drug interactions. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

What does Memantine Hydrochloride interact with?

Memantine may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Amantadine: additive central nervous system effects may increase toxicity. - Ketamine: combined NMDA antagonism can heighten neurotoxicity. - Other NMDA antagonists: concurrent use may lead to excessive receptor blockade.

Moderate Interactions (Monitor Closely): - Anticholinergics: may diminish memantine's cognitive benefits. - Diuretics: electrolyte shifts could affect neuronal stability. - CNS depressants: increased sedation or dizziness may occur.

Frequently asked questions

What is Memantina Pharma Combix used for?+
Memantina Pharma Combix contains memantine hydrochloride and is used to treat moderate to severe Alzheimer's disease. It helps improve cognition, memory, and daily functioning by modulating glutamate activity in the brain.
How does memantine work in the brain?+
Memantine acts as a non‑competitive antagonist of NMDA receptors. By blocking excessive calcium influx caused by overstimulation of these receptors, it reduces excitotoxic neuronal damage while preserving normal synaptic transmission needed for learning and memory.
What is the usual dose of Memantina Pharma Combix?+
The specific dose of Memantina Pharma Combix is determined by the prescribing clinician based on the patient’s condition, age, renal function, and other clinical factors. The prescriber will set the appropriate dosage regimen.
Is Memantina Pharma Combix safe during pregnancy or breastfeeding?+
Safety data for memantine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Memantina Pharma Combix from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does memantine compare with other Alzheimer’s treatments?+
Memantine belongs to the NMDA receptor antagonist class, differing from acetylcholinesterase inhibitors such as donepezil. While both improve symptoms, memantine targets glutamate‑mediated excitotoxicity, making it especially useful in moderate to severe stages where cholinergic agents alone may be insufficient.
What are the storage and handling requirements for Memantina Pharma Combix?+
Store the product at ambient temperature, below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.
How is Memantina Pharma Combix administered?+
Memantina Pharma Combix is taken orally, usually with or without food, as directed by the prescribing physician. The tablet (or other oral form) should be swallowed whole with a glass of water.
What are the most serious risks associated with memantine?+
Serious risks include seizures, severe allergic reactions (including anaphylaxis), hepatic dysfunction, cardiac arrhythmias, and rare skin conditions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if any of these occur.
Who should not use Memantina Pharma Combix?+
Memantina Pharma Combix should be avoided in patients with known hypersensitivity to memantine or any excipients, and used with caution in individuals with severe renal impairment, uncontrolled seizures, or significant cardiac disease. The prescriber will assess suitability on a case‑by‑case basis.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Memantine Hydrochloride
Route
Oral Use
Manufacturer
Laboratorios Combix, S.L.U.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU